This 2015 retrospective study assessed the effects of intravenous vitamin C (ascorbic acid) in 39 patients with bone metastases unresponsive to radiotherapy. Patients received high-dose intravenous vitamin C, and outcomes measured included pain levels, performance status, and survival time. The study found that vitamin C administration was associated with reduced
